pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • IBUPROFEN AND DIPHENHYDRAMINE CITRATE
    IBUPROFEN AND DIPHENHYDRAMINE CITRATE
    no indication DR REDDYS LABS LTD
  • IBUPROFEN AND FAMOTIDINE
    IBUPROFEN AND FAMOTIDINE
    no indication ALKEM LABS LTD
  • IBUPROFEN AND PSEUDOEPHEDRINE HCL
    IBUPROFEN AND PSEUDOEPHEDRINE HCL
    no indication AUROBINDO PHARMA
  • IBUPROFEN, DIPHENHYDRAMINE HCL
    IBUPROFEN, DIPHENHYDRAMINE HCL
    no indication
← prev
page 106 of 271
next →
Pain89
Neurology1
BIONPHARMA
  • Phase 2
    IC-265
    Allergic Conjunctivitis IACTA Pharmaceuticals Inc
  • Phase 2
    IC-270
    Allergic Conjunctivitis IACTA Pharmaceuticals Inc
  • ICATIBANT
    ICATIBANT
    no indication ALEMBIC
  • Preclinical
    ICEF-16
    Fecal Incontinence Innovacell Co Ltd
  • Phase 2
    ICES-13
    Stress Urinary Incontinence Innovacell Co Ltd
  • Phase 1
    ICG-122
    T-Cell Leukemia iCell Gene Therapeutics LLC
  • Phase 1
    ICG-124
    T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… iCell Gene Therapeutics LLC
  • ICOTYDE
    ICOTYDE (ICOTROKINRA HYDROCHLORIDE)
    no indication Janssen Biotech Inc
  • Phase 2
    ICT-01
    Metastatic Melanoma ImCheck Therapeutics SAS
  • Preclinical
    ICT-568
    Thyroid Cancer Innovative Cellular Therapeutics Co Ltd
  • Preclinical
    ICT-6401
    Autoimmune Disorders Innovative Cellular Therapeutics Co Ltd
  • Preclinical
    ID-119040338
    Parkinson's Disease Yunovia Co Ltd
  • Phase 1
    IDE-034
    Castration-Resistant Prostate Cancer (CRPC)$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-161
    Colon Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-275
    Endometrial Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-397
    Adenoid Cystic Carcinoma (ACC)$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    IDE-574
    Breast Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    IDE-892
    Esophageal Squamous Cell Carcinoma (ESCC)$IDYA IDEAYA Biosciences, Inc.
  • IDKIT HP ONE
    IDKIT HP ONE (CITRIC ACID ANHYDROUS AND 13C UREA)
    no indication MERIDIAN BIOSCIENCE
  • IDOSE TR
    IDOSE TR (TRAVOPROST)
    1 INDICATIONS AND USAGE iDose ® TR (travoprost intracamer…$GKOS GLAUKOS Corp
  • Phase 1
    IDOV-Immune
    Solid Tumor Viromissile Inc
  • Phase 3
    IFxHu-20
    Merkel Cell Carcinoma TuHURA Biosciences Inc
  • IGALMI
    IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE)
    1 INDICATIONS AND USAGE IGALMI is indicated for the acute…$BTAI BioXcel Therapeutics, Inc.
  • Phase 2
    IGV-001
    Glioblastoma Multiforme (GBM) Imvax Inc
  • Phase 2
    IIV-HD + rC19
    Coronavirus Disease 2019 (COVID-19)$SNY Sanofi
  • Preclinical
    IK-01400
    Inflammatory Pain InterK Peptide Therapeutics Ltd